Gaurav is a strategic and tactical operations leader, with a wealth of experience building and managing high-performing teams and developing innovative, creative, and quality-driven solutions for clients. He brings strong and varied therapeutic expertise and strategic leadership skills, developed across franchise areas within several CROs and now to Worldwide. Prior to joining Worldwide, Gaurav was a Senior Vice President and Head of Global Project Management with Premier Research. He has worked extensively in solid tumor and hematological Malignancies. More recently, Gaurav was responsible for overall successful delivery of clinical programs involving immune checkpoint inhibitors for the treatment of solid tumors and hematological malignancies.
Gaurav has also worked extensively in acute myeloid leukemia, Cutaneous T-Cell Lymphoma and Prostate Cancer. He was program director a large program with tyrosine kinase inhibitor (TKI) involving several studies, including pivotal study for patients with EGFR mutated NSCLC, leading to marketing authorization. Gaurav is a Project Management Institute (PMI) certified Project Management Professional, a Certified Director by the World Council for Corporate Governance and a Chartered Scientist (C.Sci) by the Science Council in the United Kingdom, with a wealth of experience working with pharmaceutical companies, such as Lundbeck, Allergan, Takeda, and global CROs, such as IQVIA, Parexel, Icon, Premier Research, and ClinTec.